Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:50 pm Sale | 2024-12-31 | 13G | Accelerate Diagnostics, Inc. AXDX | Armistice Capital, LLC | 2,078,000 8.250% | -322,000 (-13.42%) | Filing History |
| 2025-02-06 3:10 pm Purchase | 2025-02-04 | 13D | Accelerate Diagnostics, Inc. AXDX | Indaba Capital Management, L.P. | 2,751,762 9.900% | 149,921 (+5.76%) | Filing History |
| 2025-01-07 4:22 pm Sale | 2024-12-31 | 13G | Accelerate Diagnostics, Inc. AXDX | GRIFFIN ASSET MANAGEMENT INC. | 1,003,581 4.000% | -216,143 (-17.72%) | Filing History |
| 2024-12-05 5:13 pm Sale | 2024-12-03 | 13D | Accelerate Diagnostics, Inc. AXDX | SCHULER JACK W | 11,047,376 39.800% | -187,369 (-1.67%) | Filing History |
| 2024-11-14 3:24 pm Purchase | 2024-09-30 | 13G | Accelerate Diagnostics, Inc. AXDX | Armistice Capital, LLC | 2,400,000 9.930% | 2,400,000 (New Position) | Filing History |
| 2024-08-12 5:01 pm Purchase | 2024-08-08 | 13D | Accelerate Diagnostics, Inc. AXDX | Indaba Capital Management, L.P. | 2,601,841 9.900% | 1,004,617 (+62.90%) | Filing History |
| 2024-05-23 7:17 pm Purchase | 2024-01-19 | 13D | Accelerate Diagnostics, Inc. AXDX | SCHULER JACK W | 11,234,745 45.400% | 11,234,745 (New Position) | Filing History |
| 2024-03-05 3:59 pm Purchase | 2023-12-31 | 13G | Accelerate Diagnostics, Inc. AXDX | GRIFFIN ASSET MANAGEMENT INC. | 1,219,724 8.400% | 1,219,724 (New Position) | Filing History |
| 2023-06-20 5:26 pm Purchase | 2023-06-09 | 13D | Accelerate Diagnostics, Inc. AXDX | Indaba Capital Management, L.P. | 1,597,224 9.900% | 1,597,224 (New Position) | Filing History |
| 2023-06-20 5:10 pm Purchase | 2023-06-09 | 13D | Accelerate Diagnostics, Inc. AXDX | SCHULER JACK W | 5,801,221 40.600% | 3,775,126 (+186.33%) | Filing History |
| 2023-06-08 1:58 pm Purchase | 2023-02-15 | 13D | Accelerate Diagnostics, Inc. AXDX | SCHULER JACK W | 2,026,095 19.990% | 185,171 (+10.06%) | Filing History |
| 2022-02-24 4:20 pm Sale | 2022-02-18 | 13G | Pacific Biosciences of California, Inc. PACB | Larry N. Feinberg | 3,257,503 4.970% | -370,046 (-10.20%) | Filing History |
| 2022-02-11 4:04 pm Sale | 2021-12-31 | 13G | Pacific Biosciences of California, Inc. PACB | Larry N. Feinberg | 3,627,549 5.530% | -178,590 (-4.69%) | Filing History |
| 2021-12-02 8:05 pm Purchase | 2021-11-29 | 13D | Accelerate Diagnostics, Inc. AXDX | SCHULER JACK W | 1,840,924 26.400% | 122,228 (+7.11%) | Filing History |
| 2021-10-05 4:12 pm Purchase | 2021-09-15 | 13D | Accelerate Diagnostics, Inc. AXDX | SCHULER JACK W | 1,718,696 25.700% | 10,717 (+0.63%) | Filing History |
| 2021-02-16 4:02 pm Sale | 2020-12-31 | 13G | Pacific Biosciences of California, Inc. PACB | Larry N. Feinberg | 3,806,139 6.670% | -890,513 (-18.96%) | Filing History |
| 2021-02-12 4:48 pm Sale | 2020-12-31 | 13G | Accelerate Diagnostics, Inc. AXDX | CREDIT SUISSE AG | 176,539 3.100% | -133,836 (-43.12%) | Filing History |